Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Avono Health vs Options Medical Weight Loss

Avono Health
Graded #361

Lower grade

vs+6.799999999999997
Options Medical Weight Loss
Graded #218

Higher grade

The verdict

Options Medical Weight Loss takes it — 65.5/100 to 58.7/100.

Options Medical Weight Loss grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Options Medical Weight Loss offers telehealth medical weight-loss programs built around compounded GLP-1 — semaglutide starting around $239/month and tirzepatide from $299/month, plus NAD+ injections at…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueOptions Medical Weight Loss +24
30
54
Dose & formulationOptions Medical Weight Loss +2
75
77
Clinical oversightOptions Medical Weight Loss +1
80
81
Labs & monitoringEven
53
53
FulfillmentAvono Health +4
71
67
Contract termsOptions Medical Weight Loss +8
47
55
Avono Health · left barOptions Medical Weight Loss · right bar

The numbers

MetricAvono HealthOptions Medical Weight Loss
WeighScore58.7/10065.5/100
GradeCC
Scorecard rank#361#218
Semaglutide$269/mo (compounded)$199/mo (compounded)
Tirzepatide$349/mo (compounded)$399/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualYesInjection only
Avono Health

Graded #361 · C

Strengths

  • Transparent tiered pricing from $179/mo (microdose semaglutide injection)
  • Full compounded range — semaglutide and tirzepatide, injection and oral, microdose and standard
  • Free and discreet shipping; 24/7/365 messaging support; 100% online
  • US-licensed clinicians and pharmacies; bundle discounts at 3/6/12 months

Where it loses points

  • Medications are compounded, not FDA-approved brand-name
  • Compounding pharmacy not publicly named
  • State availability not published
  • Newer brand with limited independent review history

Strengths

  • LegitScript certified with clear, upfront program pricing
  • Compounded semaglutide (~$239) and tirzepatide (from $299), plus NAD+
  • Structured metabolic-health program with provider support and accountability
  • HSA/FSA eligible with flexible payment options

Where it loses points

  • Doesn't clearly publish which states its telehealth covers
  • Tirzepatide tiers climb to $339-$399/month
  • More program structure (and cost) than medication-only sellers
  • Compounded GLP-1 only online — no brand-name options noted

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard